Tom Williams/Vaccine

Coverage and timeliness of vaccination and the validity of routine estimates: Insights from a vaccine registry in Kenya.Adetifa IMO Karia B Mutuku A Bwanaali T Makumi A Wafula J Chome M Mwatsuma P Bauni E Hammitt LL Mataza C Tabu C Kamau T Williams TN Scott JAG
Vaccine, (2018). 36:7965-7974

High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.Polley SD Conway DJ Cavanagh DR McBride JS Lowe BS Williams TN Mwangi TW Marsh K
Vaccine, (2006). 24:4233-46

Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.Polley SD Mwangi T Kocken CH Thomas AW Dutta S Lanar DE Remarque E Ross A Williams TN Mwambingu G Lowe B Conway DJ Marsh K
Vaccine, (2004). 23:718-28